Generated by All in One SEO v4.8.5, this is an llms.txt file, used by LLMs to index the site. # Optimal Dose ## Sitemaps - [XML Sitemap](https://optimaldose.ciscientists.com/sitemap.xml): Contains all public/indexable URLs for this website. ## Posts - [Weekly News 01 August to 07 August 2026](https://optimaldose.ciscientists.com/weekly-news-01-august-to-07-august-2026/) - [U.S. Food and Drug Administration grants Breakthrough Therapy Designation to Multitude Therapeutics’ AMT-253](https://optimaldose.ciscientists.com/u-s-food-and-drug-administration-fda-grants-breakthrough-therapy-designation-to-multitude-therapeutics-amt-253/) - [FDA approves Pluvicto for PSMA+ mHSPC, advancing potential new standard of care across metastatic disease](https://optimaldose.ciscientists.com/fda-approves-pluvicto-for-psma-mhspc-advancing-potential-new-standard-of-care-across-metastatic-disease/) - [U.S. FDA grants Orphan Drug Designation to Zai Lab’s DLL3-targeting ADC Zocilurtatug pelitecan for the treatment of Neuroendocrine Carcinomas](https://optimaldose.ciscientists.com/u-s-fda-grants-orphan-drug-designation-to-zai-labs-dll3-targeting-adc-zocilurtatug-pelitecan-for-the-treatment-of-neuroendocrine-carcinomas/) - [TQB2102 receives BTD from the CDE for patients with unresectable or metastatic HER2-low Breast cancer](https://optimaldose.ciscientists.com/tqb2102-receives-btd-from-the-cde-for-patients-with-unresectable-or-metastatic-her2-low-breast-cancer/) - [Datroway approved in the EU for first-line metastatic TNBC patients unsuitable for immunotherapy](https://optimaldose.ciscientists.com/datroway-approved-in-the-eu-for-first-line-metastatic-tnbc-patients-unsuitable-for-immunotherapy/) - [Multitude Therapeutics’ AMT-676 receives Breakthrough Therapy Designation from China’s CDE](https://optimaldose.ciscientists.com/multitude-therapeutics-amt-676-receives-breakthrough-therapy-designation-from-chinas-cde/) - [Monthly Digest - August 2026](https://optimaldose.ciscientists.com/monthly-digest-august-2026/) - [Weekly News 25 July to 31 July 2026](https://optimaldose.ciscientists.com/weekly-news-25-july-to-31-july-2026/) - [Gilead announces CHMP recommendation for Trodelvy + Keytruda in 1L PD-(L)1+ mTNBC](https://optimaldose.ciscientists.com/chmp-recommends-gileads-trodelvy-plus-keytruda-for-1l-pd-l1-mtnbc/) - [AstraZeneca receives CDSCO approval for Enhertu followed by THP for adults with HER2-positive stage II or III early Breast cancer](https://optimaldose.ciscientists.com/eu-chmp-recommends-enhertu-plus-pertuzumab-for-1l-her2-metastatic-breast-cancer-2/) - [AbbVie announces availability of ELAHERE in Singapore for the treatment of platinum-resistant Ovarian cancer](https://optimaldose.ciscientists.com/abbvie-announces-availability-of-elahere-in-singapore-for-the-treatment-of-platinum-resistant-ovarian-cancer/) - [ImmunityBio receives UAE Marketing Authorization for ANKTIVA in BCG-unresponsive NMIBC (CIS and papillary disease) and mNSCLC](https://optimaldose.ciscientists.com/immunitybio-receives-uae-marketing-authorization-for-anktiva-in-bcg-unresponsive-nmibc-cis-and-papillary-disease-and-mnsclc/) - [DualityBio and BioNTech’s B7-H3 ADC DB-1311 granted China NMPA BTD for metastatic castration-resistant Prostate cancer](https://optimaldose.ciscientists.com/dualitybio-and-biontechs-b7-h3-adc-db-1311-granted-china-nmpa-btd-for-metastatic-castration-resistant-prostate-cancer/) - [EU CHMP recommends Enhertu plus Pertuzumab for 1L HER2 metastatic Breast cancer](https://optimaldose.ciscientists.com/eu-chmp-recommends-enhertu-plus-pertuzumab-for-1l-her2-metastatic-breast-cancer/) - [Weekly News 18 July to 24 July 2026](https://optimaldose.ciscientists.com/weekly-news-18-july-to-24-july-2026/) - [SEC recommends approval to Enhertu for two additional indications in India](https://optimaldose.ciscientists.com/sec-recommends-approval-to-enhertu-for-two-additional-indications-in-india/) - [Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate](https://optimaldose.ciscientists.com/samsung-bioepis-enters-into-a-commercial-license-agreement-with-intocell-for-an-adc-candidate/) - [Telix doses first patient in phase 3 LUTEON trial of TLX250-Tx for Renal cancer](https://optimaldose.ciscientists.com/telix-doses-first-patient-in-phase-3-luteon-trial-of-tlx250-tx-for-renal-cancer/) - [Medilink announces NMPA acceptance of marketing application for Tam-Peli in 3L+ NPC](https://optimaldose.ciscientists.com/medilink-announces-nmpa-acceptance-of-marketing-application-for-tam-peli-in-3l-npc/) ## Pages - [Optimal Dose - CAR-T Digest (August 2020)](https://optimaldose.ciscientists.com/) - [Weekly News 01 August to 07 August 2026](https://optimaldose.ciscientists.com/weekly-news-01-august-to-07-august-2026/) - [Monthly Digest - August 2026](https://optimaldose.ciscientists.com/monthly-digest-august-2026/) - [Weekly News 25 July to 31 July 2026](https://optimaldose.ciscientists.com/weekly-news-25-july-to-31-july-2026/) - [Weekly News 18 July to 24 July 2026](https://optimaldose.ciscientists.com/weekly-news-18-july-to-24-july-2026/) - [Weekly News 11 July to 17 July 2026](https://optimaldose.ciscientists.com/weekly-news-11-july-to-17-july-2026/) - [Weekly News 04 July to 10 July 2026](https://optimaldose.ciscientists.com/weekly-news-04-july-to-10-july-2026/) - [Weekly News 27 June to 03 July 2026](https://optimaldose.ciscientists.com/weekly-news-27-june-to-03-july-2026/) - [Monthly Digest - July 2026](https://optimaldose.ciscientists.com/monthly-digest-july-2026/) - [Weekly News 20 June to 26 June 2026](https://optimaldose.ciscientists.com/weekly-news-20-june-to-26-june-2026/) - [Weekly News 13 June to 19 June 2026](https://optimaldose.ciscientists.com/weekly-news-13-june-to-19-june-2026/) - [Weekly News 06 June to 12 June 2026](https://optimaldose.ciscientists.com/weekly-news-06-june-to-12-june-2026/) - [Weekly News 30 May to 05 June 2026](https://optimaldose.ciscientists.com/weekly-news-30-may-to-05-june-2026/) - [Monthly Digest - June 2026](https://optimaldose.ciscientists.com/monthly-digest-june-2026/) - [Weekly News 23 May to 29 May 2026](https://optimaldose.ciscientists.com/weekly-news-23-may-to-29-may-2026/) - [Weekly News 16 May to 22 May 2026](https://optimaldose.ciscientists.com/weekly-news-16-may-to-22-may-2026/) - [Weekly News 09 May to 15 May 2026](https://optimaldose.ciscientists.com/weekly-news-09-may-to-15-may-2026/) - [Weekly News 02 May to 08 May 2026](https://optimaldose.ciscientists.com/weekly-news-02-may-to-08-may-2026/) - [Weekly News 25 April to 01 May 2026](https://optimaldose.ciscientists.com/weekly-news-25-april-to-01-may-2026/) - [Monthly Digest - May 2026](https://optimaldose.ciscientists.com/monthly-digest-may-2026/) ## Post Template - [Elementor #7292](https://optimaldose.ciscientists.com/post-template/elementor-7292/) - [Elementor #7288](https://optimaldose.ciscientists.com/post-template/elementor-7288/) ## Headers - [Header 1 Sticky](https://optimaldose.ciscientists.com/header/header-1-sticky/) - [Header 1](https://optimaldose.ciscientists.com/header/header-1/) - [Header Archive](https://optimaldose.ciscientists.com/header/header-archive/) - [Header Archive Sticky](https://optimaldose.ciscientists.com/header/header-archive-sticky/) ## Footers - [Footer 1](https://optimaldose.ciscientists.com/footer/footer-1/) - [Footer 2](https://optimaldose.ciscientists.com/footer/footer-2/) - [Footer 3](https://optimaldose.ciscientists.com/footer/footer-3/) - [Footer 4](https://optimaldose.ciscientists.com/footer/footer-4/) - [Footer 5](https://optimaldose.ciscientists.com/footer/footer-5/) - [Footer 6](https://optimaldose.ciscientists.com/footer/footer-6/) - [Footer 7](https://optimaldose.ciscientists.com/footer/footer-7/) - [Footer 9](https://optimaldose.ciscientists.com/footer/footer-9/) - [Footer 8](https://optimaldose.ciscientists.com/footer/footer-8/) ## Mega Menus - [Shop](https://optimaldose.ciscientists.com/megamenu/shop/) - [Services](https://optimaldose.ciscientists.com/megamenu/services/) - [Home Demos](https://optimaldose.ciscientists.com/megamenu/home-demos/) ## Categories - [Uncategorised](https://optimaldose.ciscientists.com/category/uncategorised/) - [ADC](https://optimaldose.ciscientists.com/category/adc/) - [Regulatory](https://optimaldose.ciscientists.com/category/adc/regulatory/) - [Commercial](https://optimaldose.ciscientists.com/category/adc/commercial/) - [Clinical Trials](https://optimaldose.ciscientists.com/category/adc/clinical-trials/) - [RNAi](https://optimaldose.ciscientists.com/category/rnai/) - [Regulatory](https://optimaldose.ciscientists.com/category/rnai/regulatory-rnai/) - [Commercial](https://optimaldose.ciscientists.com/category/rnai/commercial-rnai/) - [Clinical](https://optimaldose.ciscientists.com/category/rnai/clinical/) - [CAR-T](https://optimaldose.ciscientists.com/category/car-t/) - [Clinical](https://optimaldose.ciscientists.com/category/car-t/clinical-car-t/) - [Regulatory](https://optimaldose.ciscientists.com/category/car-t/regulatory-car-t/) - [Regulatory](https://optimaldose.ciscientists.com/category/regulatory-2/) - [Commercial](https://optimaldose.ciscientists.com/category/car-t/commercial-car-t/) - [Digest](https://optimaldose.ciscientists.com/category/digest/) - [TKI](https://optimaldose.ciscientists.com/category/tki/) - [Regulatory](https://optimaldose.ciscientists.com/category/tki/regulatory-tki/) - [Clinical](https://optimaldose.ciscientists.com/category/tki/clinical-tki/) - [Respiratory](https://optimaldose.ciscientists.com/category/respiratory/) - [AstraZeneca](https://optimaldose.ciscientists.com/category/respiratory/astrazeneca/) ## Tags - [ADC Monthly Digest - Apr 2024](https://optimaldose.ciscientists.com/tag/adc-monthly-digest-apr-2024/) - [Clinical](https://optimaldose.ciscientists.com/tag/clinical/) - [Funding](https://optimaldose.ciscientists.com/tag/funding/) - [Regulatory](https://optimaldose.ciscientists.com/tag/regulatory/)